Taylor Pak

FDA Grants Approval to Repotrectinib for Locally Advanced or Metastatic Non-Small Cell Lung Cancer

December 6th 2023  /  12:15 PM PST By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On November 15, 2023, the U.S. Food…

12 months ago

Binaytara Foundation Announces 2023 Career Advancement Award Recipients

The Binaytara Foundation has proudly announced the 2023 Binaytara Career Advancement Awards recipients. The recipients of the 2023 awards attended…

12 months ago

FDA Approves Fruquintinib for Metastatic Colorectal Cancer with Prior Treatment History

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On November 8, 2023, the U.S. Food and Drug Administration granted approval to Fruquintinib…

1 year ago

Dr. Binay Shah Delivers a Keynote Lecture at the 2023 Global Oncology Summit

By: BTF Staff   October 28, 2023 – Known for its unwavering commitment to improving access to cancer care in…

1 year ago

KEYNOTE-564 trial: KEYTRUDA® (pembrolizumab) Improves Overall Survival in Renal Cell Carcinoma Patients Post-Nephrectomy

By: Dr. Anish Shah  Bronx-Lebanon Hospital; Bronx, NY Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), significantly improves overall survival (OS) in renal cell…

1 year ago